Preventing Spread of HIV in Jails: Best Window of Opportunity Early in Incarceration

November 25, 2009

( -- With World AIDS Day less than a week away, two new studies from Yale School of Medicine show that jail inmates, one of the highest risk groups for AIDS, are far more likely to be tested for HIV if given the opportunity in the first 24 hours of incarceration. The studies, which could lead to better prevention and earlier and more effective treatment of inmates, are published in the November 25 issue of PLoS ONE, a journal of the Public Library of Science.

The research was spearheaded by a Yale medical student, Ravi Kavasery, under the mentorship of Frederick Altice, M.D., professor of medicine and director of clinical and community research for the Yale Program and principal investigator of grants from the National Institutes of Drug Abuse and the Health Services Resources Agency, which funded this research.

The two Yale studies, both prospective controlled trials involving more than 600 Connecticut detainees, looked at the willingness of men and women to be screened for HIV as part of the routine while entering the correctional system. Of the 298 newly imprisoned men, the greatest proportion accepted testing on the day after incarceration—53 percent. Those offered testing on the same day as incarceration had a somewhat lower rate of acceptance, 45 percent. After a week, the testing rate dropped significantly, to 33 percent.

The second study involved 323 newly incarcerated women and showed a similar trend: the best time to offer HIV screening was the day after incarceration, when 73 percent received testing. Rates were lower on the actual day of entry - 55 percent - and even more so after seven days, at 50 percent.

“More than a quarter of people with HIV in the U.S. have no idea that they are infected and continue unknowingly to engage in high-risk behaviors,” noted Altice, the principal investigator on the studies. “Just letting them know they have HIV results in impressive reductions in sexual risk-taking.”

Lead author Kavasery said, “The findings from our studies have two major public health implications. First, we show that offering routine opt-out HIV testing in jails is feasible. Second, and perhaps more importantly, our studies demonstrate that offering testing within the first 24 hours of admission results in the highest number of individuals receiving testing.”

The participation of medical students in research projects is an integral part of medical education at Yale. Each medical student must complete a research thesis prior to graduation, a requirement for graduation since 1839. “Ravi’s contribution to this research project is the caliber of research we expect from our students,” noted John Forrest, M.D., professor of medicine and director of student research at Yale. “Getting two first-authored publications in a top-tier journal speaks to the quality.” Kavasery also oversaw the scientific rigor of the men’s study, where 5 additional students from the School of Public Health participated as part of their community project.

“I’ve been fortunate to have had the luxury of working with a number of remarkably talented and accomplished students over the years. It humbles me to see their abilities harnessed to create new knowledge while simultaneously contributing to science and socially responsible research,” Altice said. Forrest indicated that more than 75% of Yale medical students publish their research in peer-reviewed journals or present their work at national research meetings. “Yale leads the country in the quantity of important medical research done by ,” Forrest said.

Provided by Yale University (news : web)

Related Stories

Recommended for you

Scientists find where HIV 'hides' to evade detection by the immune system

October 19, 2017
In a decades-long game of hide and seek, scientists from Sydney's Westmead Institute for Medical Research have confirmed for the very first time the specific immune memory T-cells where infectious HIV 'hides' in the human ...

National roll-out of PrEP HIV prevention drug would be cost-effective

October 18, 2017
Providing pre-exposure prophylaxis (PrEP) medication to men who have sex with men who are at high risk of HIV infection (equivalent to less than 5% of men who have sex with men at any point in time) in England would be cost-effective, ...

Regulatory T cells harbor HIV/SIV virus during antiviral drug treatment

October 17, 2017
Scientists at Yerkes National Primate Research Center, Emory University have identified an additional part of the HIV reservoir, immune cells that survive and harbor the virus despite long-term treatment with antiviral drugs.

New research opens the door to 'functional cure' for HIV

October 17, 2017
In findings that open the door to a completely different approach to curing HIV infections, scientists from the Florida campus of The Scripps Research Institute (TSRI) have for the first time shown that a novel compound effectively ...

Researchers create molecule that could 'kick and kill' HIV

October 5, 2017
Current anti-AIDS drugs are highly effective at making HIV undetectable and allowing people with the virus to live longer, healthier lives. The treatments, a class of medications called antiretroviral therapy, also greatly ...

A sixth of new HIV patients in Europe 50 or older: study

September 27, 2017
People aged 50 and older comprise a growing percentage of HIV patients in Europe, accounting for one in six new cases in 2015, researchers said Wednesday.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.